Johnson & Johnson Transformative Research Award supports interdisciplinary teams of established investigators studying prostate or bladder malignant disease to develop new insights or solutions.
Funder: American Urological Association
Due Dates: November 13, 2026 (Applications open) | January 11, 2027 (Full proposal)
Funding Amounts: One award of up to $120,000 over two years, capped at $60,000 annually
Summary: Supports interdisciplinary teams of established investigators researching prostate or bladder malignant disease.
Key Information: Exactly two independent PIs are required: one with urologic expertise and one from another discipline.
The Johnson & Johnson Transformative Research Award fosters collaboration between established urologic researchers and experts from other disciplines. Administered by the American Urological Association Education and Research (AUAER) Office of Research through the Urology Care Foundation, the award encourages investigators outside urology to bring complementary expertise to urologic challenges. The 2027 competition focuses on prostate or bladder malignant disease.
The program supports research that challenges existing paradigms, examines longstanding problems from new perspectives, or introduces novel concepts, approaches, methodologies, technologies, or interventions, including artificial intelligence. Projects may involve basic, foundational, translational, clinical, or health services research. The jointly developed proposal must demonstrate how the interdisciplinary partnership enables insights or solutions difficult to achieve through a single discipline.